Cargando…
Will the real disease gene please stand up?
A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive signals, their follow-up with association studies and discrimination between true and false positive results. Several strategies for overcoming these issues have been devised. Using the Genetic Analy...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866716/ https://www.ncbi.nlm.nih.gov/pubmed/16451679 http://dx.doi.org/10.1186/1471-2156-6-S1-S66 |
_version_ | 1782133308021276672 |
---|---|
author | Shephard, Neil John, Sally Cardon, Lon McCarthy, Mark I Zeggini, Eleftheria |
author_facet | Shephard, Neil John, Sally Cardon, Lon McCarthy, Mark I Zeggini, Eleftheria |
author_sort | Shephard, Neil |
collection | PubMed |
description | A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive signals, their follow-up with association studies and discrimination between true and false positive results. Several strategies for overcoming these issues have been devised. Using the Genetic Analysis Workshop 14 simulated dataset, we aimed to apply different analytical approaches and evaluate their performance in discerning real associations. We considered a) haplotype analyses, b) different methods adjusting for multiple testing, c) replication in a second dataset, and d) exhaustive genotyping of all markers in a sufficiently powered, large sample group. We found that haplotype-based analyses did not substantially improve over single-point analysis, although this may reflect the low levels of linkage disequilibrium simulated in the datasets provided. Multiple testing correction methods were in general found to be over-conservative. Replication of nominally positive results in a second dataset appears to be less stringent, resulting in the follow-up of false positives. Performing a comprehensive assay of all markers in a large, well-powered dataset appears to be the most effective strategy for complex disease gene identification. |
format | Text |
id | pubmed-1866716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-18667162007-05-11 Will the real disease gene please stand up? Shephard, Neil John, Sally Cardon, Lon McCarthy, Mark I Zeggini, Eleftheria BMC Genet Proceedings A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive signals, their follow-up with association studies and discrimination between true and false positive results. Several strategies for overcoming these issues have been devised. Using the Genetic Analysis Workshop 14 simulated dataset, we aimed to apply different analytical approaches and evaluate their performance in discerning real associations. We considered a) haplotype analyses, b) different methods adjusting for multiple testing, c) replication in a second dataset, and d) exhaustive genotyping of all markers in a sufficiently powered, large sample group. We found that haplotype-based analyses did not substantially improve over single-point analysis, although this may reflect the low levels of linkage disequilibrium simulated in the datasets provided. Multiple testing correction methods were in general found to be over-conservative. Replication of nominally positive results in a second dataset appears to be less stringent, resulting in the follow-up of false positives. Performing a comprehensive assay of all markers in a large, well-powered dataset appears to be the most effective strategy for complex disease gene identification. BioMed Central 2005-12-30 /pmc/articles/PMC1866716/ /pubmed/16451679 http://dx.doi.org/10.1186/1471-2156-6-S1-S66 Text en Copyright © 2005 Shephard et al; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Proceedings Shephard, Neil John, Sally Cardon, Lon McCarthy, Mark I Zeggini, Eleftheria Will the real disease gene please stand up? |
title | Will the real disease gene please stand up? |
title_full | Will the real disease gene please stand up? |
title_fullStr | Will the real disease gene please stand up? |
title_full_unstemmed | Will the real disease gene please stand up? |
title_short | Will the real disease gene please stand up? |
title_sort | will the real disease gene please stand up? |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866716/ https://www.ncbi.nlm.nih.gov/pubmed/16451679 http://dx.doi.org/10.1186/1471-2156-6-S1-S66 |
work_keys_str_mv | AT shephardneil willtherealdiseasegenepleasestandup AT johnsally willtherealdiseasegenepleasestandup AT cardonlon willtherealdiseasegenepleasestandup AT mccarthymarki willtherealdiseasegenepleasestandup AT zegginieleftheria willtherealdiseasegenepleasestandup |